Company research / PLUR

Pluri Inc. (PLUR)

CIK 0001158780 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, Pluri Inc. reported revenue of $1.02M. Revenue fell 24.0% from the prior annual period.

Key ratios (year ended 2026-06-30)

44.6%
Gross margin
n/m
Operating margin
n/m
Net margin
-24.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-K (annual report) · 2026-09-10

Headquarters locality: Haifa · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Stock splits: 1-for-8, first reflected in a filing dated 2024-05-09. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView